Nikos Stergiopoulos is a Professor and Director of the Laboratory of Hemodynamics and Cardiovascular Technology, Federal University of Lausanne, Switzerland. He studied Mechanical Engineering at the National Technical University of Athens and received his PhD in Biomedical Technology from Iowa State University, USA, in 1990. Nikos Stergiopoulos also holds an MBA from IMD. Today he is a professor and director of the laboratory of hemodynamic and cardiovascular technology at the Technical University of Lausanne.His main research interests are hemodynamics, cardiovascular engineering and medical technology. He has over 200 publications in reputable journals and holds more than 15 patents in the field of medical technology. In 1998 he founded EndoArt SA, a leading implant company for the surgical treatment of congenital heart disease and morbid obesity. He is the founder and CEO of Rheon Medical, an implant manufacturer for the surgical treatment of glaucoma, as well as Comphya SA, which deals with the treatment of erectile dysfunction through electrostimulation.
Nikos Stergiopoulos
Professor
Technical University of Lausanne
